BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30815254)

  • 1. Extended-spectrum beta-lactamase production and multi-drug resistance among
    Teklu DS; Negeri AA; Legese MH; Bedada TL; Woldemariam HK; Tullu KD
    Antimicrob Resist Infect Control; 2019; 8():39. PubMed ID: 30815254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia.
    Tekele SG; Teklu DS; Tullu KD; Birru SK; Legese MH
    PLoS One; 2020; 15(11):e0241984. PubMed ID: 33180785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of fecal carriage of Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among food handlers at the University of Gondar, Northwest Ethiopia.
    Amare A; Eshetie S; Kasew D; Moges F
    PLoS One; 2022; 17(3):e0264818. PubMed ID: 35298493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia.
    Abera B; Kibret M; Mulu W
    PLoS One; 2016; 11(11):e0166519. PubMed ID: 27846254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S; Gaind R; Ranjan R; Deb M
    J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
    Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
    J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-Resistant and Carbapenemase-Producing
    Tekele SG; Teklu DS; Legese MH; Weldehana DG; Belete MA; Tullu KD; Birru SK
    Biomed Res Int; 2021; 2021():9999638. PubMed ID: 34195291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia.
    Beyene D; Bitew A; Fantew S; Mihret A; Evans M
    PLoS One; 2019; 14(9):e0222911. PubMed ID: 31553773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug-resistance and extended-spectrum beta-lactamase-producing lactose-fermenting enterobacteriaceae in the human-dairy interface in northwest Ethiopia.
    Beyene AM; Gizachew M; Yousef AE; Haileyesus H; Abdelhamid AG; Berju A; Tebeje MM; Feleke T; Gelaw B
    PLoS One; 2024; 19(5):e0303872. PubMed ID: 38771780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing
    Tadesse S; Mulu W; Genet C; Kibret M; Belete MA
    Biomed Res Int; 2022; 2022():5727638. PubMed ID: 35155675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
    Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
    J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods.
    Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K
    J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.
    Zeynudin A; Pritsch M; Schubert S; Messerer M; Liegl G; Hoelscher M; Belachew T; Wieser A
    BMC Infect Dis; 2018 Oct; 18(1):524. PubMed ID: 30342476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence and characterization of extended-spectrum ß-lactamase producing Enterobacteriaceae in Chadian hospitals.
    Ouchar Mahamat O; Lounnas M; Hide M; Dumont Y; Tidjani A; Kamougam K; Abderrahmane M; Benavides J; Solassol J; Bañuls AL; Jean-Pierre H; Carrière C; Godreuil S
    BMC Infect Dis; 2019 Feb; 19(1):205. PubMed ID: 30819135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.
    Poulou A; Grivakou E; Vrioni G; Koumaki V; Pittaras T; Pournaras S; Tsakris A
    J Clin Microbiol; 2014 May; 52(5):1483-9. PubMed ID: 24574283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae.
    Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D
    J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of three microbiological methods for detection of expanded-spectrum betalactamases in Enterobacteriaceae isolated in Santa Fe (Argentina)].
    Truppia LA; Mollerach A; Di Conza JA; Radice M; Mugna V; Méndez E; Gutkind GO
    Enferm Infecc Microbiol Clin; 2005 Nov; 23(9):525-8. PubMed ID: 16324563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Magnitude of Carbapenemase and ESBL Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia.
    Seman A; Sebre S; Awoke T; Yeshitela B; Asseffa A; Asrat D; Abebe T; Mihret A
    Adv Exp Med Biol; 2022; 1369():117-128. PubMed ID: 34914083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.